Contact
HomeAboutCase StudiesCareersCareers
Contact
Product Fit
Regulatory
IP
Clinical
Commercialization

€1.3M Grant Raised to Launch a University-Hospital Pathology Spin-Out

2026
Pathology
Class I - Exempt

Product Fit

Regulatory

IP

Clinical

Commercialization

Context

Contrary to popular advice, Faros does not always recommend that international medical startups incorporate nor fundraise in the US first.

For this German university-hospital  pathology project, the product has an impactful  clinical and commercial potential. However,  the market size made it difficult at this early stage to position as a traditional venture-backable opportunity.

The team needed a way to fund development and launch without relying on US venture capital. They also needed a credible commercialization strategy that could support both a European launch and future US market entry.

Solution

Faros worked with the university-hospital tech transfer team to position their researcher’s  invention as a commercially viable spin-out with a clear path into the market.

We achieved that by crafting a strategy focused on non-dilutive local grant funding. Faros was positioned as the US development and commercialization partner, giving the grant application a stronger translational credibility and international market-entry narrative.

This helped the team secure over €1.3M in Germany to build and commercialize the product across Germany and the US.

‍

Context

Contrary to popular advice, Faros does not always recommend that international medical startups incorporate nor fundraise in the US first.

For this German university-hospital  pathology project, the product has an impactful  clinical and commercial potential. However,  the market size made it difficult at this early stage to position as a traditional venture-backable opportunity.

The team needed a way to fund development and launch without relying on US venture capital. They also needed a credible commercialization strategy that could support both a European launch and future US market entry.

Solution

Faros worked with the university-hospital tech transfer team to position their researcher’s  invention as a commercially viable spin-out with a clear path into the market.

We achieved that by crafting a strategy focused on non-dilutive local grant funding. Faros was positioned as the US development and commercialization partner, giving the grant application a stronger translational credibility and international market-entry narrative.

This helped the team secure over €1.3M in Germany to build and commercialize the product across Germany and the US.

‍

Impact

€1.3M Raised

The team secured over €1.3M in German grant funding to support company formation, product development, and commercialization.

Spin-Out Pathway Created

Faros helped position the project as a launchable university spin-out rather than a traditional venture-backed startup.

US Market Strategy to Increase Funding odds

The grant application was strengthened by presenting Faros as the company’s US commercialization partner.

“You dont always have to look at the US as your source of funding, even when it is the largest commercial market out there”

Sarah Wilson
HR Manager